* Nemaura Medical Inc NMRD.OQ reported a quarterly adjusted
loss of 9 cents per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
* Reported revenue was zero; analysts expected zero.
* Nemaura Medical Inc's reported EPS for the quarter was a loss
of 9 cents.
* The mean earnings estimate of analysts was unchanged in the
last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Nemaura Medical Inc shares had fallen by 15.0% this
quarter and gained 133.4% so far this year.
* The company reported a quarterly loss of $2.13 million.
* Wall Street's median 12-month price target for Nemaura Medical
Inc is $15.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated July 7 at 08:40 a.m.. All
figures in July 7